155 related articles for article (PubMed ID: 32100570)
1. Developing agents for the therapeutic prevention of melanoma: can the assessment of cutaneous precursor lesions help?
Maguire WF; Kirkwood JM
Future Oncol; 2020 Mar; 16(9):413-415. PubMed ID: 32100570
[No Abstract] [Full Text] [Related]
2. What about chemoprevention for melanoma?
Demierre MF
Curr Opin Oncol; 2006 Mar; 18(2):180-4. PubMed ID: 16462188
[TBL] [Abstract][Full Text] [Related]
3. The prevention of cutaneous malignant melanoma: high-risk groups, chemoprevention, education, and screening.
Greene MH
Cancer Treat Res; 1993; 65():103-40. PubMed ID: 8104019
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials.
Jeter JM; Bowles TL; Curiel-Lewandrowski C; Swetter SM; Filipp FV; Abdel-Malek ZA; Geskin LJ; Brewer JD; Arbiser JL; Gershenwald JE; Chu EY; Kirkwood JM; Box NF; Funchain P; Fisher DE; Kendra KL; Marghoob AA; Chen SC; Ming ME; Albertini MR; Vetto JT; Margolin KA; Pagoto SL; Hay JL; Grossman D; Ellis DL; Kashani-Sabet M; Mangold AR; Markovic SN; Meyskens FL; Nelson KC; Powers JG; Robinson JK; Sahni D; Sekulic A; Sondak VK; Wei ML; Zager JS; Dellavalle RP; Thompson JA; Weinstock MA; Leachman SA; Cassidy PB
Cancer; 2019 Jan; 125(1):18-44. PubMed ID: 30281145
[TBL] [Abstract][Full Text] [Related]
5. The 'ugly duckling' sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening.
Grob JJ; Bonerandi JJ
Arch Dermatol; 1998 Jan; 134(1):103-4. PubMed ID: 9449921
[No Abstract] [Full Text] [Related]
6. Melanoma Chemoprevention: Current Status and Future Prospects.
Chhabra G; Ndiaye MA; Garcia-Peterson LM; Ahmad N
Photochem Photobiol; 2017 Jul; 93(4):975-989. PubMed ID: 28295364
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of serial biopsies of large dysplastic nevi as a melanoma chemoprevention model.
Lao CD; Johnson T; Sondak VK; Lowe L; Kim DS; Zhao L; Naftanel M; Olsen S; Brenner DE
J Am Acad Dermatol; 2011 Jun; 64(6):1188-90. PubMed ID: 21571186
[No Abstract] [Full Text] [Related]
8. Nevi, other than dysplastic and Spitz nevi.
Cochran AJ; Bailly C; Paul E; Dolbeau D
Semin Diagn Pathol; 1993 Feb; 10(1):3-17. PubMed ID: 8506415
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous melanocytic lesions: selected problem areas.
Wick MR; Patterson JW
Am J Clin Pathol; 2005 Dec; 124 Suppl():S52-83. PubMed ID: 16468418
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of skin melanoma: facts and myths.
Uzarska M; Czajkowski R; Schwartz RA; Bajek A; Zegarska B; Drewa T
Melanoma Res; 2013 Dec; 23(6):426-33. PubMed ID: 24077511
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of melanoma.
Demierre MF; Merlino G
Curr Oncol Rep; 2004 Sep; 6(5):406-13. PubMed ID: 15291986
[TBL] [Abstract][Full Text] [Related]
12. Prevention of non-melanoma skin cancer.
Stratton SP
Curr Oncol Rep; 2001 Jul; 3(4):295-300. PubMed ID: 11389812
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Biodistribution of Sulforaphane after Administration of Oral Broccoli Sprout Extract in Melanoma Patients with Multiple Atypical Nevi.
Tahata S; Singh SV; Lin Y; Hahm ER; Beumer JH; Christner SM; Rao UN; Sander C; Tarhini AA; Tawbi H; Ferris LK; Wilson M; Rose A; Dietz CM; Hughes E; Fahey JW; Leachman SA; Cassidy PB; Butterfield LH; Zarour HM; Kirkwood JM
Cancer Prev Res (Phila); 2018 Jul; 11(7):429-438. PubMed ID: 29691233
[TBL] [Abstract][Full Text] [Related]
14. Malignant melanoma and its precursors. The growing need for early identification.
Evans JF; Miller OF
Postgrad Med; 1986 Feb; 79(2):215-22. PubMed ID: 3945597
[TBL] [Abstract][Full Text] [Related]
15. Use of oral N-acetylcysteine for protection of melanocytic nevi against UV-induced oxidative stress: towards a novel paradigm for melanoma chemoprevention.
Goodson AG; Cotter MA; Cassidy P; Wade M; Florell SR; Liu T; Boucher KM; Grossman D
Clin Cancer Res; 2009 Dec; 15(23):7434-40. PubMed ID: 19920101
[TBL] [Abstract][Full Text] [Related]
16. [Nevi, sun and the risk of melanoma].
Snellman E; Koulu L; Rantanen T
Duodecim; 2002; 118(4):359-66; quiz 366, 401. PubMed ID: 12233040
[No Abstract] [Full Text] [Related]
17. Primary cutaneous malignant melanoma and its precursor lesions: diagnostic and therapeutic overview.
Kanzler MH; Mraz-Gernhard S
J Am Acad Dermatol; 2001 Aug; 45(2):260-76. PubMed ID: 11464189
[TBL] [Abstract][Full Text] [Related]
18. Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of tumor thickness.
Sagebiel RW
J Invest Dermatol; 1993 Mar; 100(3):322S-325S. PubMed ID: 8440914
[TBL] [Abstract][Full Text] [Related]
19. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
Skender-Kalnenas TM; English DR; Heenan PJ
J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
[TBL] [Abstract][Full Text] [Related]
20. Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma.
Harris GR; Shea CR; Horenstein MG; Reed JA; Burchette JL; Prieto VG
Am J Surg Pathol; 1999 Jul; 23(7):786-94. PubMed ID: 10403301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
